Cargando…

Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs)

Perinatal hypoxic-ischemic encephalopathy (HIE) is the leading cause of mortality and morbidity in neonates, with survivors suffering significant neurological sequelae including cerebral palsy, epilepsy, intellectual disability and autism spectrum disorders. While hypothermia is used clinically to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Adam B., Anderton, Ryan S., Knuckey, Neville W., Meloni, Bruno P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119922/ https://www.ncbi.nlm.nih.gov/pubmed/30087289 http://dx.doi.org/10.3390/brainsci8080147

Ejemplares similares

Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action
por: Meloni, Bruno P., et al.
Publicado: (2020)

Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat
por: Edwards, Adam B., et al.
Publicado: (2018)

Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis
por: Edwards, Adam B., et al.
Publicado: (2022)

Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis
por: Meloni, Bruno P., et al.
Publicado: (2022)

Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity
por: MacDougall, Gabriella, et al.
Publicado: (2019)

Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model
por: Milani, Diego, et al.
Publicado: (2016)

Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011)

Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies
por: Milani, Diego, et al.
Publicado: (2018)

Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function
por: MacDougall, Gabriella, et al.
Publicado: (2020)

New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy
por: Victor, Suresh, et al.
Publicado: (2021)

Perinatal Azithromycin Provides Limited Neuroprotection in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
por: Mike, Jana Krystofova, et al.
Publicado: (2023)

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
por: Taniguchi, Hidetoshi, et al.
Publicado: (2008)

Cell-based treatment for perinatal hypoxic-ischemic encephalopathy
por: Park, You Jeong, et al.
Publicado: (2021)

Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
por: Dixon, Brandon J., et al.
Publicado: (2015)

Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat
por: Liddle, Lane, et al.
Publicado: (2019)

Neuroprotective Effects of MicroRNA-210 on Hypoxic-Ischemic Encephalopathy
por: Qiu, Jie, et al.
Publicado: (2013)

Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
por: Sameshima, Hiroshi, et al.
Publicado: (2013)

Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
por: Mamsa, Somayra S. A., et al.
Publicado: (2021)

Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010)

Neuroprotective Therapies after Perinatal Hypoxic-Ischemic Brain Injury
por: de Cerio, Felipe Goñi, et al.
Publicado: (2013)

Effect of Polyarginine Peptide R18D Following a Traumatic Brain Injury in Sprague-Dawley Rats
por: Chiu, Li Shan, et al.
Publicado: (2020)

Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?
por: Hendaus, Mohamed A, et al.
Publicado: (2016)

RETRACTION: eNOS Gene Polymorphisms in Perinatal Hypoxic-Ischemic Encephalopathy
Publicado: (2019)

Efficiency Evaluation of Neuroprotection for Therapeutic Hypothermia to Neonatal Hypoxic-Ischemic Encephalopathy
por: Weng, Bowen, et al.
Publicado: (2021)

Thiamine as a Possible Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Encephalopathy
por: Sechi, Gian Pietro, et al.
Publicado: (2021)

The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat
por: Milani, D., et al.
Publicado: (2016)

Perinatal Hypoxic-Ischemic Encephalopathy: epileptic and paretic outcome at one year of age
por: Allemand, Federico, et al.
Publicado: (2009)

Magnetic Resonance Imaging Evaluation of Perinatal Hypoxic Ischemic Encephalopathy: An Institutional Experience
por: Reddy, Ravikanth
Publicado: (2022)

Necroptosis Blockade Potentiates the Neuroprotective Effect of Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy
por: Chevin, Mathilde, et al.
Publicado: (2022)

Pathophysiology and Neuroprotective Strategies in Hypoxic-Ischemic Brain Injury and Stroke
por: Meloni, Bruno P.
Publicado: (2017)

Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy
por: Distefano, Giuseppe, et al.
Publicado: (2010)

Increase of Parkin and ATG5 plasmatic levels following perinatal hypoxic-ischemic encephalopathy
por: Tarocco, Anna, et al.
Publicado: (2022)

Peptide-Stabilized Emulsions and Gels from an Arginine-Rich Surfactant-like Peptide with Antimicrobial Activity
por: Castelletto, Valeria, et al.
Publicado: (2019)

A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy – are we there yet?
por: Schulzke, Sven M, et al.
Publicado: (2007)

Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy
por: Park, Won Soon, et al.
Publicado: (2015)

Preterm Hypoxic–Ischemic Encephalopathy
por: Gopagondanahalli, Krishna Revanna, et al.
Publicado: (2016)

Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury
por: Lara-Celador, I., et al.
Publicado: (2013)

The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
por: Duranti, Andrea, et al.
Publicado: (2022)

Peptidomic Analysis of Neonate Umbilical Cord Blood for the Identification of Endogenous Peptides Involved in Hypoxic–Ischemic Encephalopathy
por: Dong, Xiaohua, et al.
Publicado: (2021)

Assessing Creatine Supplementation for Neuroprotection against Perinatal Hypoxic-Ischaemic Encephalopathy: A Systematic Review of Perinatal and Adult Pre-Clinical Studies
por: Tran, Nhi Thao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1h2tk9mr3p1ld026ng27rek2mf